TAK logo

TAK EBITDA Margin

Latest reported27.75%
TAK TTM EBITDA Margin (37.27% → 27.75%)
High-resolution chart · PNG

TAK ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
27.7468%
29.542%
30.5336%
25.13%
26.6498%
24.9494%
28.4903%
30.1049%
25.6746%
26.0486%
23.2045%
25.8559%
29.5506%
30.2601%
29.1687%
28.0846%
28.0796%
30.1583%
32.8853%
34.0005%
32.9388%
30.7622%
26.3464%
24.005%
24.0346%
19.2098%
20.4727%
19.3773%
19.2014%
21.7092%
19.579%
21.3429%
19.2297%
25.2851%
25.8617%
24.168%
24.1132%
20.9981%
22.6014%
22.6333%
23.9746%
18.3772%
3.58%
6.7315%
6.578%
7.4338%
26.4954%
25.0322%
26.2304%
25.5141%
21.9854%
19.8696%
19.343%
18.0431%
-5.9543%
1.9897%
8.1957%
18.0011%
25.9045%
29.2105%
32.6925%
34.1244%
33.2903%
33.8512%
34.4631%
36.5866%
36.9159%
39.4341%
37.2711%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.